Assessing Coughing and Wheezing in Lung Cancer: A Pilot Study
Lung
Site-Specific Cancer Series: Lung Cancer Online Course
14.2 Contact Hours
Supported through an educational grant from AstraZeneca to ONS.
This site specific online course would provide detailed information to help nurses understand the current management of lung cancer. Based on the ONS publication Site-Specific Cancer Series: Lung Cancer, the course will address the following:
- Biology and therapeutic implications
- Cancer control issues
- Patient Assessment
- Oncologic urgencies and emergencies
- Symptom management
The Individual and The Evidence: Treating Advanced Non-Small Cell Lung Cancer
Expiration: 7/9/2009
1.2 Contact Hours
Supported by sanofi-aventis, u.s.inc.
The goal of this webcast is to provide the participant with the means to challenge current thinking about the individualized treatment of the patient with non-small cell lung cancer including dose-intense therapy with an eye toward improved patient outcomes.
Site-Specific Cancer Series: Lung Cancer - The first volume in the Site-Specific Cancer Series, Lung Cancer provides a comprehensive review of the current knowledge related to this deadly disease. You will find pertinent information on prevention, screening, diagnosis, clinical manifestations, treatment and research, and nursing management.
Lung Cancer Clinical Resource Area - Lung cancer treatment is complex. Fourteen percent of people who develop lung cancer survive for five years, and their treatment path is arduous. This resource area provides access to the latest evidenced-based information on delivering quality lung cancer care.
Lung Cancer Clinical Resource Area & Lung Cancer Patient Resource Area - More Americans die each year from lung cancer than from breast, prostate, and colorectal cancers combined. Approximately 174,470 new cases of lung cancer will be diagnosed in 2006, accounting for 12% of all new cancer cases. Lung cancer surpasses breast cancer as the leading cancer killer for women. More than 87% of lung cancers are smoking related but, not all smokers develop lung cancer. Supported by an educational grant from AstraZeneca